New Episode Out Now – Mounjaro & More
Curious about the latest breakthroughs in treating type 2 diabetes and obesity?
In our latest podcast episode, we break down the science behind Mounjaro (tirzepatide)—a next-generation medication targeting both GIP and GLP-1 receptors. Learn how it works, what makes it different from other treatments like Ozempic® and Saxenda®, and what clinical trials reveal about its weight loss potential.
We also dive into key topics like side effects, long-term management challenges, lifestyle integration, and the future of drug discovery through AI.
Whether you're a healthcare professional, patient, or just want to stay informed—this is essential listening.
Click here to get started https://youtu.be/M1srV-o96EA
#MounjaroAndMore #Tirzepatide #Mounjaro #Type2Diabetes #ObesityTreatment #GLP1Agonist #GIPReceptor #Ozempic #Wegovy #Saxenda #WeightLossMedications #DiabetesCare #MetabolicHealth #ClinicalTrials #LifestyleMedicine #AIinHealthcare #HealthcarePodcast
YouTube
Mounjaro & More: Understanding Modern Treatments for Diabetes and Obesity
Welcome to Mounjaro & More, the audio podcast dedicated to unraveling the complexities of modern treatments for type 2 diabetes and obesity. In this episode, we'll delve into the science behind groundbreaking medications like Mounjaro (tirzepatide), a unique…
April 24, 2025 2.2K 2
